TherapeuticsMD, Inc. - FORM 10-K - EX-32.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER

Attached files

file	filename
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - TherapeuticsMD, Inc.	ex32-1.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - TherapeuticsMD, Inc.	ex31-2.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - TherapeuticsMD, Inc.	ex31-1.htm
EX-23.1 - CONSENT OF GRANT THORNTON LLP - TherapeuticsMD, Inc.	ex23-1.htm
EX-21.1 - SUBSIDIARIES OF THE COMPANY - TherapeuticsMD, Inc.	ex21-1.htm
EX-10.18 - AMENDMENT NO. 1 TO THE FINANCING AGREEMENT - TherapeuticsMD, Inc.	ex10-18.htm
EX-4.2 - DESCRIPTION OF SECURITIES OF THE COMPANY - TherapeuticsMD, Inc.	ex4-2.htm
10-K - ANNUAL REPORT - TherapeuticsMD, Inc.	txmd-10k_123119.htm

TherapeuticsMD, Inc. 10-K

Exhibit 32.2

SECTION 1350 CERTIFICATION OF CHIEF FINANCIAL OFFICER

In connection with the annual report of TherapeuticsMD, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Daniel A. Cartwright, Chief Financial Officer of the Company, certify, to my best knowledge and belief, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(3)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and

(4)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

February 24, 2020

	/s/ Daniel A. Cartwright
	Daniel A. Cartwright
	Chief Financial Officer
	(Principal Financial and Accounting Officer)

A signed original of this certification has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Attached files

TherapeuticsMD, Inc. Reports

Also read